YU47555B - Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje - Google Patents

Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje

Info

Publication number
YU47555B
YU47555B YU19890A YU19890A YU47555B YU 47555 B YU47555 B YU 47555B YU 19890 A YU19890 A YU 19890A YU 19890 A YU19890 A YU 19890A YU 47555 B YU47555 B YU 47555B
Authority
YU
Yugoslavia
Prior art keywords
group
tetrahydrobenzimidazol
derivatives
procedure
production
Prior art date
Application number
YU19890A
Other languages
English (en)
Other versions
YU19890A (sh
Inventor
M. Ohta
T. Koide
T. Suzuki
A. Matsuhisa
K. Miyata
J. Ohmori
I. Yanagisawa
Original Assignee
Yamanouchi Pharmaceutical Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27458302&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU47555(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Yamanouchi Pharmaceutical Co. Ltd. filed Critical Yamanouchi Pharmaceutical Co. Ltd.
Priority to SI9010198A priority Critical patent/SI9010198B/sl
Publication of YU19890A publication Critical patent/YU19890A/sh
Publication of YU47555B publication Critical patent/YU47555B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Derivati tetrahidroben-zimidazola predstavljen formulom (I): naznačen time, što Het predstavlja jednu heterocikličnu grupu koja se može supstituisati 1 do 3 supstituentima, izabranim iz grupe koja se sastoji od jedne niže alkilne grupe, jedne niže alkenilne grupe, jedne niže alkinilne grupe, jedne cikloalkil-niže alkilne grupe, jedne aralkilne grupe, jedne niže alkoksi grupe, jedne nitro grupe, jedne hidroksilne grupe, jedne niže alkoksikarbonilne grupe i jednog halogenog atoma, a X prestavlja jednu jednostuku vezu ili -NH- koji je vezan za atom ugljenika ili atom azota heterocikličnog prstena, ili soli istoga. Prijava sadrži još 1 nezavisan i 16 zavisnih zahteva.
YU19890A 1989-02-02 1990-02-02 Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje YU47555B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SI9010198A SI9010198B (sl) 1989-02-02 1990-02-02 Derivati tetrahidrobenzimidazola in postopek za njihovo pripravo

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2539789 1989-02-02
JP4889789 1989-02-28
JP27344489 1989-10-20
JP34293989 1989-12-28

Publications (2)

Publication Number Publication Date
YU19890A YU19890A (sh) 1992-09-07
YU47555B true YU47555B (sh) 1995-10-03

Family

ID=27458302

Family Applications (1)

Application Number Title Priority Date Filing Date
YU19890A YU47555B (sh) 1989-02-02 1990-02-02 Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje

Country Status (14)

Country Link
EP (1) EP0381422B1 (sh)
JP (1) JPH0625153B2 (sh)
KR (1) KR930011038B1 (sh)
CN (1) CN1030252C (sh)
AT (1) ATE144511T1 (sh)
AU (1) AU626980B2 (sh)
DE (1) DE69028934T2 (sh)
DK (1) DK0381422T3 (sh)
ES (1) ES2095855T3 (sh)
FI (1) FI104720B (sh)
GR (1) GR3022123T3 (sh)
HU (2) HU205350B (sh)
NO (1) NO177007C (sh)
YU (1) YU47555B (sh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−３−カルボン酸誘導体
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
WO1995009168A1 (fr) * 1993-09-30 1995-04-06 Tokyo Tanabe Company Limited Compose d'indoline et antagoniste des recepteurs de 5-ht3 contenant ce compose comme principe actif
WO1995009167A1 (fr) * 1993-09-30 1995-04-06 Tokyo Tanabe Company Limited Derive d'indoline et antagoniste du recepteur 5-ht3 contenant ce derive et utilise comme ingredient actif
IL128642A0 (en) * 1996-09-04 2000-01-31 Pfizer Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
HUP0101275A3 (en) 1998-03-26 2002-12-28 Japan Tobacco Inc Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists
JP2003527395A (ja) * 2000-03-17 2003-09-16 ノボ ノルディスク アクティーゼルスカブ ヒスタミンｈ３受容体リガンドとしての縮環イミダゾール
US6437147B1 (en) 2000-03-17 2002-08-20 Novo Nordisk Imidazole compounds
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
KR20010112015A (ko) * 2000-06-13 2001-12-20 정화영 굴껍질성분을 소재로 한 도자기제품의 제조방법
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds
JP4909068B2 (ja) * 2003-02-14 2012-04-04 グラクソ グループ リミテッド カルボキサミド誘導体
RU2314808C2 (ru) * 2004-01-30 2008-01-20 Астеллас Фарма Инк. Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
CN1315823C (zh) * 2004-11-02 2007-05-16 天津康鸿医药科技发展有限公司 一种合成盐酸雷莫司琼的新方法
CN100436451C (zh) * 2005-04-11 2008-11-26 安斯泰来制药株式会社 拉莫司琼或其盐的新制造方法
CN100390165C (zh) * 2005-06-24 2008-05-28 天津康鸿医药科技发展有限公司 一种含烷酰基雷莫司琼的药物组合物及其应用
WO2008032726A1 (fr) 2006-09-15 2008-03-20 Astellas Pharma Inc. Composition pharmaceutique solide pour administration orale comprenant du ramosétron optiquement stable
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
RU2608458C2 (ru) 2009-05-20 2017-01-18 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Антагонисты серотониновых 5-нт3-рецепторов для применения при лечении вестибулярных нарушений с повреждениями
CN102101858B (zh) * 2009-12-21 2014-12-31 天津康鸿医药科技发展有限公司 雷莫司琼衍生物及其制备方法和用途
CN105669655A (zh) * 2016-03-01 2016-06-15 苏州艾缇克药物化学有限公司 一种雷莫司琼的合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
CA2004911A1 (en) * 1988-12-22 1990-06-22 Mitsuaki Ohta 4,5,6,7-tetrahydrobenzimidazole derivatives

Also Published As

Publication number Publication date
YU19890A (sh) 1992-09-07
HU900636D0 (en) 1990-04-28
HU211874A9 (en) 1995-12-28
KR930011038B1 (ko) 1993-11-20
AU626980B2 (en) 1992-08-13
KR900012914A (ko) 1990-09-03
EP0381422B1 (en) 1996-10-23
NO177007B (no) 1995-03-27
JPH0625153B2 (ja) 1994-04-06
JPH03223278A (ja) 1991-10-02
EP0381422A1 (en) 1990-08-08
DK0381422T3 (da) 1997-03-10
CN1030252C (zh) 1995-11-15
DE69028934T2 (de) 1997-03-20
GR3022123T3 (en) 1997-03-31
ES2095855T3 (es) 1997-03-01
FI104720B (fi) 2000-03-31
ATE144511T1 (de) 1996-11-15
HU205350B (en) 1992-04-28
CN1045583A (zh) 1990-09-26
NO900487L (no) 1990-08-03
NO177007C (no) 1995-07-05
DE69028934D1 (de) 1996-11-28
HUT53099A (en) 1990-09-28
AU4889090A (en) 1990-08-09
FI900477A0 (fi) 1990-01-31
NO900487D0 (no) 1990-02-01

Similar Documents

Publication Publication Date Title
YU47555B (sh) Derivati tetrahidrobenzimidazola i postupak za njihovo dobijanje
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
DE60311821D1 (de) Dibenzylaminverbindung und deren medizinische verwendung
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
PT86183A (en) Process for preparing imidazolidinedione derivatives
DE68911006D1 (de) Pharmakologisch-aktive Alkylthiobenzimidazol-Derivate und Verfahren zu deren Herstellung.
DE69128272D1 (de) Piperazinderivate
ES2072193B1 (es) Nuevos derivados del1-fenilmetil bencimidazol piperacinas.
EP0798304A4 (en) DRUGS AGAINST TRHOMBOCYTOPENIA
CA2008815A1 (en) Tetrahydrobenzimidazole derivatives